In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Energy Manager News
- Energy-as-a-Service: Charting a Path Through Complexity
- Demand Energy, EnerSys Complete Storage Project
- Lunera Intros Pathway and Entryway LED
- FPL to Buy and Phase Out Coal-Powered Plant, Saving Customers $129M
- Environmental, Health and Safety Software Moves Forward
- Johnson Controls: Interest, Investment in Energy Efficiency Up
- First-Ever Statewide Endorsement of Retail Supplier, by Delaware, Goes to Direct Energy
- Oberlin, Ohio, Ratepayers to Receive $2.2M in Rebates for Sale of RECs